Outcome Measure | Preoperative | Six-mo Follow-Up | P Value |
Single-level ESLD | |||
MF FCSA (in mm2) | |||
Ipsilateral | 594.47 ± 208.24 | 604.56 ± 199.99 | 0.112 |
Contralateral | 597.96 ± 227.05 | 613.79 ± 219.18 | 0.66 |
ES FCSA (in mm2) | |||
Ipsilateral | 1101.26 ± 429.1 | 1177.88 ± 636.6 | 0.123 |
Contralateral | 1138.26 ± 465.4 | 1144.65 ± 463.2 | 0.621 |
Fatty infiltration scale, n (%) | |||
0 | 47 (39.83) | 62 (52.54) | 0.221 |
1 | 51 (43.22) | 42 (35.59) | 0.358 |
2 | 22 (16.95) | 14 (11.86) | 0.119 |
DS CSA (in mm2) | 79.23 ± 28.54 | 163.97 ± 37.86 | <0.001* |
Multilevel ESLD | |||
MF FCSA (in mm2) | |||
Ipsilateral | 513.81 ± 198.56 | 520.92 ± 189.22 | 0.458 |
Contralateral | 507.48 ± 218.49 | 516.23 ± 206.64 | 0.344 |
ES FCSA (in mm2) | |||
Ipsilateral | 1316.89 ± 523.7 | 1332.92 ± 541.68 | 0.432 |
Contralateral | 1296.36 ± 563.25 | 1316.27 ± 563.43 | 0.311 |
Fatty infiltration scale, n (%) | |||
0 | 37 (97.37) | 38 (100) | 0.865 |
1 | 33 (86.84) | 33 (86.84) | 0.697 |
2 | 13 (28.95) | 10 (26.32) | 0.771 |
DS CSA (in mm2) | 69.83 ± 19.94 | 157.81 ± 23.6 | <0.001* |
Note: Data presented as mean ± SD unless otherwise noted. Statistically significant values are marked with an asterisk (*).
CSA, cross-sectional area; DS, dural sac; ES, erector spinae; ESLD, end-stage liver disease; FCSA, functional cross-sectional area; MF, multifidus.